MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2012-4003

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2013

Pharmacodynamics of cinacalcet over 48 hours in patients with controlled secondary hyperparathyroidism: useful data in clinical practice.

Arenas M Dolores, de la Fuente Vanesa, Delgado Pablo, Gil María Teresa, Gutiérrez Patricia, Ribero Jorge, Rodríguez Mariano, Almadén Yolanda

Клиническое исследование IV фазыСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

CONTEXT: Cinacalcet induces immediate changes in serum PTH levels, but the pharmacodynamic effect throughout the daily dosing interval in controlled patients is unknown. Also, in patients with reduced PTH, it is unknown what happens in the first 24 hours after withdrawal.

OBJECTIVE

Our aim was to describe the effect over 48 hours of cinacalcet in hemodialysis patients with controlled secondary hyperparathyroidism.

DESIGN

This was a phase 4, open-label, single-arm, single-dose, single-center clinical trial.

SETTING

The study was conducted at a public hospital (Hospital Perpetuo Socorro, Alicante, Spain).

PATIENTS: We included 10 patients on cinacalcet for 6 months or longer with intact PTH (iPTH) levels 100-400 pg/mL [8 men, mean age of 66 years (range 39-82 years)], chronically treated with 30 mg (n = 6), 60 mg (n = 3), or 90 mg (n = 1) of cinacalcet.

INTERVENTION: A single dose (30-90 mg) was administered at baseline.

MAIN OUTCOME MEASURES: iPTH (Duo Kit Scantibodies and Elecsys Roche), PTH 1-84, ionized calcium, phosphorus (P), and calcitonin were determined at baseline and at 1, 3, 6, 12, 24, and 48 hours.

RESULTS

There was a significant reduction in iPTH between 1 and 6 hours, and values returned to baseline at 24 hours [maximum mean (95% confidence interval) percent change from baseline: -50%(-34; -66) at 3 hours]. A transient increase in calcitonin and a decrease in P were also observed, with no changes in calcium. At 48 hours, there was a significant increase in iPTH [+51% (26; 76)] and P. Changes in PTH were similar with the 3 determination methods.

CONCLUSIONS

In hemodialysis patients with secondary hyperparathyroidism controlled by cinacalcet, a transient (1-6 hours) reduction in PTH and P and an increase in calcitonin are observed after each daily dose, with return to baseline at 24 hours. After calcimimetics discontinuation, PTH was significantly increased at 48 hours. The assay used to measure PTH does not influence relative changes induced by cinacalcet.

Для цитирования: Arenas M Dolores, de la Fuente Vanesa, Delgado Pablo, Gil María Teresa, Gutiérrez Patricia, Ribero Jorge, Rodríguez Mariano, Almadén Yolanda. Pharmacodynamics of cinacalcet over 48 hours in patients with controlled secondary hyperparathyroidism: useful data in clinical practice.. The Journal of clinical endocrinology and metabolism. 2013. DOI: 10.1210/jc.2012-4003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.